[go: up one dir, main page]

AR039275A1 - Medicamento que contiene esteroides y un nuevo anticolinergico - Google Patents

Medicamento que contiene esteroides y un nuevo anticolinergico

Info

Publication number
AR039275A1
AR039275A1 ARP030101241A ARP030101241A AR039275A1 AR 039275 A1 AR039275 A1 AR 039275A1 AR P030101241 A ARP030101241 A AR P030101241A AR P030101241 A ARP030101241 A AR P030101241A AR 039275 A1 AR039275 A1 AR 039275A1
Authority
AR
Argentina
Prior art keywords
polinergy
new anti
diastereoisomers
containing steroids
medicinal containing
Prior art date
Application number
ARP030101241A
Other languages
English (en)
Inventor
Banholzer Rolf Dr
Helmut Meissner
Gerd Morschhaeuser
Pieper Michael P Dr
Pohl Gerald Dr
Reichl Richard Dr
Speck Georg Dr
Montague Christopher John Dr
Pairet Michel Dr
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of AR039275A1 publication Critical patent/AR039275A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicación 1: Medicamento, caracterizado por un contenido en una o varias, preferiblemente una sal de la fórmula (1) en donde X- significa un anión cargado negativamente de forma sencilla, preferiblemente un anión elegido del grupo consistente en cloruro, bromuro, yoduro, sulfato, fosfato, metanosulfonato, nitrato, maleato, acetato, citrato, fumarato, tartrato, oxalato, succinato, benzoato y p-toluenosulfonato, en combinación con uno o varios, preferiblemente un esteroide 2, eventualmente en forma de sus diastereoisómeros, mezclas de los diastereoisómeros o en forma de los racematos, eventualmente en forma de los solvatos e hidratos así como eventualmente, junto con un coadyuvante farmacéuticamente compatible.
ARP030101241A 2002-04-12 2003-04-09 Medicamento que contiene esteroides y un nuevo anticolinergico AR039275A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10216429A DE10216429A1 (de) 2002-04-12 2002-04-12 Arzneimittel enthaltend Steroide und ein neues Anticholinergikum

Publications (1)

Publication Number Publication Date
AR039275A1 true AR039275A1 (es) 2005-02-16

Family

ID=28458802

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101241A AR039275A1 (es) 2002-04-12 2003-04-09 Medicamento que contiene esteroides y un nuevo anticolinergico

Country Status (29)

Country Link
EP (2) EP1496902B1 (es)
JP (1) JP4559086B2 (es)
KR (1) KR101010869B1 (es)
CN (1) CN1646126A (es)
AR (1) AR039275A1 (es)
AT (1) ATE312607T1 (es)
AU (1) AU2003216921B2 (es)
BR (1) BR0309085A (es)
CA (1) CA2481268C (es)
DE (2) DE10216429A1 (es)
DK (1) DK1496902T3 (es)
EA (1) EA008386B1 (es)
EC (1) ECSP045355A (es)
ES (1) ES2254917T3 (es)
HR (1) HRP20040943B1 (es)
IL (2) IL164391A0 (es)
ME (1) MEP54208A (es)
MX (1) MXPA04009917A (es)
MY (1) MY137045A (es)
NO (1) NO20044097L (es)
NZ (1) NZ536284A (es)
PE (1) PE20040326A1 (es)
PL (1) PL211227B1 (es)
RS (1) RS50776B (es)
TW (1) TWI311055B (es)
UA (1) UA80125C2 (es)
UY (1) UY27758A1 (es)
WO (1) WO2003086399A1 (es)
ZA (1) ZA200406751B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US7291608B2 (en) 2001-04-30 2007-11-06 Glaxo Group Limited Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
RU2440813C2 (ru) 2004-02-06 2012-01-27 Меда Фарма Гмбх Унд Ко.Кг Комбинация (варианты) и фармацевтический препарат для лечения заболеваний дыхательных путей
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
SMT202000077T1 (it) 2009-05-29 2020-03-13 Pearl Therapeutics Inc Composizioni per il rilascio polmonare di antagonisti muscarinici a lunga durata e agonisti dei recettori beta-2 adrenergici a lunga durata e metodi e sistemi associati
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN115282411A (zh) * 2022-01-14 2022-11-04 温州医科大学 利用鼻嗅区递送药物入脑的输送系统及其应用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FR2585563B1 (fr) 1985-07-30 1993-11-12 Glaxo Group Ltd Dispositif pour administrer des medicaments a des patients
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4108393A1 (de) 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
IL107120A (en) 1992-09-29 1997-09-30 Boehringer Ingelheim Int Atomising nozzle and filter and spray generating device
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
AU700837B2 (en) * 1995-04-28 1999-01-14 Banyu Pharmaceutical Co., Ltd. 1,4-di-substituted piperidine derivatives
DE19536903C2 (de) 1995-10-04 1998-09-10 Boehringer Ingelheim Int Vorrichtung zum Haltern eines fluidischen Bauteils
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE19545226C1 (de) 1995-12-05 1997-06-19 Boehringer Ingelheim Int Sperrspannwerk für einen federbetätigten Abtrieb
GB0009591D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical combinations
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
WO2002036106A2 (de) * 2000-10-31 2002-05-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden

Also Published As

Publication number Publication date
CN1646126A (zh) 2005-07-27
ES2254917T3 (es) 2006-06-16
UY27758A1 (es) 2003-11-28
RS89904A (sr) 2006-10-27
EP1621197A3 (de) 2010-01-06
MEP54208A (en) 2011-05-10
BR0309085A (pt) 2005-02-09
KR20050000391A (ko) 2005-01-03
DE10216429A1 (de) 2003-10-23
WO2003086399A1 (de) 2003-10-23
AU2003216921B2 (en) 2008-03-13
ECSP045355A (es) 2005-01-28
NO20044097L (no) 2004-11-04
HRP20040943A2 (en) 2005-04-30
MY137045A (en) 2008-12-31
EP1496902B1 (de) 2005-12-14
EA008386B1 (ru) 2007-04-27
JP4559086B2 (ja) 2010-10-06
RS50776B (sr) 2010-08-31
CA2481268A1 (en) 2003-10-23
TWI311055B (en) 2009-06-21
IL164391A (en) 2010-11-30
ATE312607T1 (de) 2005-12-15
PL371561A1 (en) 2005-06-27
KR101010869B1 (ko) 2011-01-26
ZA200406751B (en) 2006-12-27
EP1621197A2 (de) 2006-02-01
MXPA04009917A (es) 2004-12-07
NZ536284A (en) 2006-11-30
JP2005529105A (ja) 2005-09-29
CA2481268C (en) 2011-07-12
AU2003216921A1 (en) 2003-10-27
DE50301934D1 (de) 2006-01-19
DK1496902T3 (da) 2006-05-08
HRP20040943B1 (hr) 2013-05-31
PE20040326A1 (es) 2004-07-13
TW200403062A (en) 2004-03-01
UA80125C2 (en) 2007-08-27
PL211227B1 (pl) 2012-04-30
EA200401303A1 (ru) 2005-04-28
IL164391A0 (en) 2005-12-18
EP1496902A1 (de) 2005-01-19

Similar Documents

Publication Publication Date Title
AR039275A1 (es) Medicamento que contiene esteroides y un nuevo anticolinergico
UY28527A1 (es) Formularios de aerosol destinadaa la inhalación, que contiene un agente anticolinergico
CO5540380A2 (es) Medicamentos inhalativos que contienen un nuevo anticolinergico en combinacion con corticosteroides y betamimeticos
CO6170341A2 (es) Formulacion de aerosol que contiene derivados de benzoxazin-3onas
HRP20031066B1 (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
WO2005035514A3 (en) Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
DE50105729D1 (de) Arzneimittelkompositionen auf der basis von tiotropiumsalzen und salzen des salmeterols
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
SE0202430D0 (sv) New Compounds
MXPA02010542A (es) Minimizacion de experiencias adversas asociadas con la terapia con oxibutinina.
AR058082A1 (es) Formulacion en aerosol para la inhalacion de beta- agonistas
AR039404A1 (es) Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion
AR102640A1 (es) Composición para cuidado bucal que contiene sales de zinc y carbonato de calcio
EA200700686A1 (ru) Липосомы, включающие радиоактивный изотоп, и цитотоксический агент для комбинированной терапии
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
AR049096A1 (es) Formulacion en aerosol sin gas propelente para la inhalacion de beta-agonistas
NL7801650A (nl) Nieuwe 1-/(diarylmethyl)-aminoalkyl/ piperidinen met neuroleptische werkzaamheid, alsmede thera- peutische preparaten, die deze nieuwe piperidi- nen als werkzame stof bevatten.
AR059126A1 (es) Uso de sales de tiotropio en el tratamiento del asma persistente moderada
AR055597A1 (es) Uso de sales de tiotripio en el tratamiento del asma persistente severa
CN206687178U (zh) 电子烟及雾化装置
CO5700760A2 (es) Nuevas composiciones de medicamentos a base de nuevos anti- colinergicos e inhibidores de egfr-quinasa
AR040864A1 (es) Formulacion aerosol para inhalacion, que contiene un agente anticolinergico
AU2003208703A1 (en) Difurylglycolic acid tropenol esters used as anticholinesterase drugs
TH65935A (th) ยาซึ่งประกอบรวมด้วยสเตอรอยด์ และแอนตีโคลิเนอร์จิคตัวใหม่
JPS5316527A (en) Display address generator

Legal Events

Date Code Title Description
FB Suspension of granting procedure